Targeting mutant estrogen receptors

A drug used in hormone replacement therapy can target estrogen receptors that have become resistant to breast cancer treatments.

Detalles Bibliográficos
Autores principales: Wardell, Suzanne E, Norris, John D, McDonnell, Donald P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335051/
https://www.ncbi.nlm.nih.gov/pubmed/30648967
http://dx.doi.org/10.7554/eLife.44181